Skip to main navigation Skip to search Skip to main content

In vivo protection by broadly neutralizing HIV antibodies

Research output: Contribution to journalEditorialAcademicpeer-review

Abstract

Passive immunization studies, including a recent one by Pegu et al., have repeatedly shown that HIV-specific broadly neutralizing antibodies (bnAbs) protect rhesus macaques from HIV acquisition. In vitro neutralization potency and in vivo protection correlate very strongly, supporting the quest for an HIV vaccine that induces potent bnAbs
Original languageEnglish
Pages (from-to)550-551
JournalTrends in microbiology
Volume22
Issue number10
DOIs
Publication statusPublished - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'In vivo protection by broadly neutralizing HIV antibodies'. Together they form a unique fingerprint.

Cite this